CINECA IRIS Institutional Research Information System

MANCUSO, MICHELANGELO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.044
AS - Asia 10.670
EU - Europa 7.937
SA - Sud America 1.975
AF - Africa 563
OC - Oceania 46
Continente sconosciuto - Info sul continente non disponibili 11
Totale 45.246
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.368
SG - Singapore 3.513
CN - Cina 2.796
IT - Italia 2.620
HK - Hong Kong 1.835
BR - Brasile 1.615
SE - Svezia 1.148
DE - Germania 1.080
VN - Vietnam 903
BG - Bulgaria 689
GB - Regno Unito 463
CA - Canada 459
TR - Turchia 446
FR - Francia 401
FI - Finlandia 338
RU - Federazione Russa 328
UA - Ucraina 247
IN - India 226
AT - Austria 193
CI - Costa d'Avorio 187
JP - Giappone 180
BD - Bangladesh 121
AR - Argentina 114
KR - Corea 111
MX - Messico 110
CH - Svizzera 98
IQ - Iraq 87
SN - Senegal 67
NL - Olanda 65
NG - Nigeria 61
PK - Pakistan 61
ZA - Sudafrica 59
ES - Italia 52
EC - Ecuador 50
MA - Marocco 50
IL - Israele 47
BE - Belgio 46
ID - Indonesia 46
CO - Colombia 44
PL - Polonia 44
VE - Venezuela 38
SA - Arabia Saudita 37
UZ - Uzbekistan 34
CL - Cile 29
KE - Kenya 29
EG - Egitto 28
NZ - Nuova Zelanda 24
PE - Perù 23
UY - Uruguay 23
PY - Paraguay 22
AU - Australia 21
PH - Filippine 21
MY - Malesia 19
AZ - Azerbaigian 18
TN - Tunisia 18
IR - Iran 17
NP - Nepal 17
CZ - Repubblica Ceca 16
PA - Panama 16
IE - Irlanda 15
JM - Giamaica 15
OM - Oman 15
JO - Giordania 14
AE - Emirati Arabi Uniti 13
DK - Danimarca 13
RO - Romania 13
BO - Bolivia 12
CR - Costa Rica 12
ET - Etiopia 12
BJ - Benin 11
DZ - Algeria 10
LB - Libano 10
DO - Repubblica Dominicana 9
GR - Grecia 9
KZ - Kazakistan 9
LT - Lituania 9
NI - Nicaragua 9
TH - Thailandia 9
TT - Trinidad e Tobago 9
AL - Albania 8
BH - Bahrain 8
EU - Europa 8
HN - Honduras 8
KG - Kirghizistan 8
PT - Portogallo 8
TW - Taiwan 8
GE - Georgia 7
GT - Guatemala 7
BB - Barbados 6
HU - Ungheria 6
PS - Palestinian Territory 6
SY - Repubblica araba siriana 5
AM - Armenia 4
BA - Bosnia-Erzegovina 4
CG - Congo 4
LV - Lettonia 4
AO - Angola 3
BS - Bahamas 3
CU - Cuba 3
CY - Cipro 3
Totale 45.167
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.446
Ashburn 2.376
Singapore 1.998
Fairfield 1.952
Hong Kong 1.804
Houston 1.565
Ann Arbor 1.441
San Jose 1.193
Chandler 1.170
Dallas 1.165
Santa Clara 1.131
Seattle 871
Milan 713
Sofia 686
Wilmington 676
Shanghai 674
Cambridge 621
Beijing 601
Serra 584
New York 483
Boardman 346
Ottawa 333
Los Angeles 329
Jacksonville 314
Princeton 289
Lawrence 273
Izmir 261
Lauterbourg 254
Medford 245
Ho Chi Minh City 227
Abidjan 187
Nanjing 183
Council Bluffs 172
Frankfurt am Main 166
Tokyo 164
Florence 160
Hefei 158
Vienna 150
Hanoi 140
Des Moines 134
Istanbul 133
São Paulo 125
Munich 123
Buffalo 119
Redondo Beach 111
San Diego 106
Seoul 102
Rome 99
Dong Ket 96
London 95
Pisa 93
Columbus 87
Nanchang 84
Bern 83
The Dalles 80
Helsinki 79
Dearborn 71
Ogden 70
Dakar 67
Redwood City 62
Lagos 60
Orem 60
Norwalk 59
Jüchen 58
Turku 54
Kunming 53
Chicago 49
Belo Horizonte 48
Bremen 48
Fuzhou 46
Nuremberg 46
Rio de Janeiro 46
Hebei 44
Lancaster 44
Brussels 39
Washington 38
Düsseldorf 37
Boulder 36
Changsha 35
Pune 35
Shenyang 35
Warsaw 34
Tashkent 32
Lappeenranta 31
Phoenix 31
San Francisco 31
Brooklyn 30
Falls Church 30
Montreal 30
Toronto 30
Dhaka 29
Stockholm 29
Atlanta 28
Baghdad 28
Da Nang 28
Jiaxing 27
Guangzhou 26
Nairobi 26
Curitiba 25
Haiphong 25
Totale 32.040
Salva come PNG Salva come JPEG
Nome #
Lack of association between the APEX1 Asp148Glu polymorphism and sporadic Amyotrophic Lateral Sclerosis 780
IER-SICH Nomogram to Predict Symptomatic Intracerebral Hemorrhage After Thrombectomy for Stroke 273
Myopathic involvement and mitochondrial pathology in Kennedy disease and in other motor neuron diseases 246
Vascular Factors and Mitochondrial Dysfunction: a Central Role in the Pathogenesis of Alzheimer's Disease. 244
Endothelium and oxidative stress: The Pandora's Box of cerebral (and non-only) small vessel disease? 244
Autosomal dominant psychiatric disorders and mitochondrial DNA multiple deletions: report of a family 240
Nerve and muscle involvement in mitochondrial disorders: an electrophysiological study. 239
Oxidative stress in cerebral small vessel disease dizziness patients, basally and after polyphenol compound supplementation 239
Metabolic myopathies: functional evaluation by different exercise testing approaches 232
Antimyoclonic effect of levetiracetam in MERRF syndrome 231
Hereditary spastic paraparesis in adults. A clinical and genetic perspective from Tuscany 229
Tetracycline treatment in patients with progressive external ophthalmoplegia. 228
Mitochondrial cascade hypothesis of Alzheimer's disease: myth or reality? 225
Mitochondrial DNA-related disorders 225
Oxidative stress treatment for clinical trials in neurodegenerative diseases. 223
Association study between XRCC1 gene polymorphisms and sporadic amyotrophic lateral sclerosis 223
Lack of association between the APEX1 Asp148Glu polymorphism and sporadic amyotrophic lateral sclerosis 221
Timing of initiation of oral anticoagulants in patients with acute ischemic stroke and atrial fibrillation comparing posterior and anterior circulation strokes 221
Gly482Ser PGC-1α gene polymorphism and exercise-related oxidative stress in amyotrophic lateral sclerosis patients 218
"Mitochondrial neuropathies": A survey from the large cohort of the Italian Network 217
Mitochondria, cognitive impairment, and Alzheimer's disease. 215
Decreased platelet cytochrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease 213
An atypical presentation of sporadic adult-onset centronuclear myopathy 213
Hemorrhagic transformation in patients with acute ischemic stroke and atrial fibrillation: Time to initiation of oral anticoagulant therapy and outcomes 212
Diagnostic Approach to Mitochondrial Disorders: the Need for a Reliable Biomarker 211
Is erythropoietin gene a modifier factor in amyotrophic lateral sclerosis? 211
Antioxidant capacity and protein oxidation in cerebrospinal fluid of amyotrophic lateral sclerosis 209
A novel mitochondrial tRNA(Ile) point mutation associated with chronic progressive external ophthalmoplegia and hyperCKemia. 208
Pes cavus and hereditary neuropathies: when a relationship should be suspected. 206
Mitochondrial non-syndromic sensorineural hearing loss: a clinical, audiological and pathological study from Italy, and revision of the literature 205
Lack of association between mtDNA haplogroups and Alzheimer's disease in Tuscany 205
Mitochondrial DNA haplogroups may influence Fabry disease phenotype 204
May "mitochondrial eve" and mitochondrial haplogroups play a role in neurodegeneration and Alzheimer's disease? 204
A novel mitochondrial tRNAPhe mutation causes MERRF syndrome 204
Anticoagulation After Stroke in Patients With Atrial Fibrillation 204
Inflammatory myopathy in a patient with postural and kinetik tremor. 203
Causes and Risk Factors of Cerebral Ischemic Events in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention 203
Reply to P.M. Foye ( Letter ) 202
A mitochondrial tRNAPhe mutation causes MERRF syndrome [Sindrome MERRF associata a mutazione del tRNAPhe] 200
Psychiatric involvement in adult patients with mitochondrial disease. 200
Mitochondria and neurodegeneration 198
Cerebral sinus venous thrombosis: Clinical and pathogenetic perspectives from Tuscany 198
Brain MRI in Monogenic Cerebral Small Vessel Diseases: A Practical Handbook 198
The Role of Mitochondria in StemCell Biology 196
DNMT3B promoter polymorphisms and risk of late onset Alzheimer's disease. 196
.Mitochondria, mitochondrial DNA and Alzheimer's disease. What comes first? 195
Lack of association between nuclear factor erythroid-derived 2-like 2 promoter gene polymorphisms and oxidative stress biomarkers in amyotrophic lateral sclerosis patients 195
Mitochondrial DNA single deletion in a patient with postural tremor. 194
Phenotypic heterogeneity of the 8344A>G mtDNA "MERRF" mutation. 194
Novel spastin (SPG4) mutations in Italian patients with hereditary spastic paraplegia 193
Effects of aerobic training on exercise-related oxidative stress in mitochondrial myopathies. 192
COX AND MITOCHONDRIAL F1F0-ATPASE (ATP SYNTHASE) ACTIVITIES IN PLATELETS AND BRAIN FROM PATIENTS WITH ALZHEIMER'S DISEASE 191
.Clinical features and pathogenesis of Alzheimer's disease: involvement of mitochondria and mitochondrial DNA. 191
Oxidative stress biomarkers in patients with untreated obstructive sleep apnea syndrome. 191
Acute encephalopathy of the temporal lobes leading to m.3243A>G. When MELAS is not always MELAS 190
Epilepsy and limb girdle muscular dystrophy type 2A: double trouble, serendipitous finding or new phenotype? 188
Cardiac involvement in chronic progressive external ophthalmoplegia 188
Mitochondrial dysfunction and Alzheimer's disease: new developments 187
Nerve and muscle involvement in mitochondrial disorders: an electrophysiological study. 187
Coenzyme Q10, exercise lactate and CTG trinucleotide expansion in myotonic dystrophy 187
Epidemiology and cerebrovascular events related to cervical and intracranial arteries dissection: the experience of the city of Pisa 187
Mitochondrial DNA sequence variation and neurodegeneration. 186
Iron-sensitive MR imaging of the primary motor cortex to differentiate hereditary spastic paraplegia from other motor neuron diseases 186
Aging with Cerebral Small Vessel Disease and Dizziness: The Importance of Undiagnosed Peripheral Vestibular Disorders 185
Amyotrophic Lateral Sclerosis and Oxidative Stress: a Double-Blind Therapeutic Trial After Curcumin Supplementation 183
Mitochondrial peripheral benzodiazepine receptor in amyotrophic lateral sclerosis 182
Electron transfer mediators and other metabolites and cofactors in the treatment of mitochondrial dysfunction 182
Assessment of endogenous DNA oxidative stress in mitochondrial encephalomyopathies. 181
Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations. 180
No evidence for allelic association of serotonin 2A receptor and transporter gene polymorphisms with depression in Alzheimer disease 180
H-MTTFA muscle levels in mitochondrial myopathies. 180
MULTIPLE CRANIAL NERVE PALSIES IN TESTICULAR LYMPHOMA: REPORT OF A CASE 179
Early recurrence in paroxysmal versus sustained atrial fibrillation in patients with acute ischaemic stroke 179
Coenzyme Q10 in neuromuscular and neurodegenerative disorders 177
Metabolic muscle adaptation to aerobic training in patients affected by mitochondrial myopathies. 177
Genetics of ischaemic stroke in young adults 177
Drugs and mitochondrial diseases: 40 queries and answers. 176
TARDBP (TDP-43) sequence analysis in patients with familial and sporadic ALS: identification of two novel mutations 174
Common Genetic Conditions of Ischemic Stroke to Keep in Mind 174
Efficacy and Safety of Ticagrelor and Aspirin in Patients With Moderate Ischemic Stroke: An Exploratory Analysis of the THALES Randomized Clinical Trial 174
Proximal Myopathy due to m.5835G>A Mutation in Mitochondrial MT-TY Gene 174
Abnormal H-Tfam in a patient harboring a single mtDNA deletion. 173
Early Recurrence and Major Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation Treated With Non-Vitamin-K Oral Anticoagulants (RAF-NOACs) Study 173
Targeting mitochondrial dysfunction and neurodegeneration by means of coenzyme Q10 and its analogues. 172
POLG1-related and other "mitochondrial Parkinsonisms": an overview. 172
G41S SOD1 mutation: A common ancestor for six ALS Italian families with an aggressive phenotype 172
Vertebrobasilar recording with contrast transcranial Doppler in right-to-left shunt diagnosis 172
Risk for major bleeding in patients receiving ticagrelor compared with aspirin after transient ischemic attack or acute ischemic stroke in the SOCRATES study (acute stroke or transient ischemic attack treated with aspirin or ticagrelor and patient outcomes) 171
Abnormal levels of human mitochondrial transcription factor A in skeletal muscle in mitochondrial encephalomyopathies. 170
Redefining phenotypes associated with mitochondrial DNA single deletion 168
A new truncating MPZ mutation associated with a very mild CMT1 B phenotype 167
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 167
CPEO and Mitochondrial Myopathy in a Patient with DGUOK Compound Heterozygous Pathogenetic Variant and mtDNA Multiple Deletions 167
Levetiracetam-responsive myoclonus in spinocerebellar ataxia type 15. 166
APOE and Alzheimer disease: a major gene with semi-dominant inheritance. 165
Antimyoclonic effect of Levetiracetam in MERRF syndrome [Efficacia antimioclonica di Levetiracetam nella Sindrome MERRF] 164
Metabolic and muscle adaptation to aerobic training in CPEO patients. 164
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 164
DPP6 gene variability confers increased risk of developing sporadic amyotrophic lateral sclerosis in Italian patients. 164
A non-syndromic hearing loss caused by very low levels of the mtDNA A3243G mutation 163
Totale 20.146
Salva come PNG Salva come JPEG
Categoria #
all - tutte 131.092
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 131.092
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.953 55 197 68 185 561 382 87 168 139 76 249 786
2022/20233.767 443 480 246 329 450 445 35 293 716 25 268 37
2023/20243.176 353 307 348 210 432 542 128 92 46 188 187 343
2024/20259.712 31 349 91 574 932 945 1.008 559 918 1.203 1.023 2.079
2025/202611.051 663 1.340 1.305 907 1.098 962 1.546 580 572 924 927 227
2026/202754 54 0 0 0 0 0 0 0 0 0 0 0
Totale 45.777